Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?

Table 1

Summary of patient characteristics, preoperative management, endoscopic findings, and subsequent treatment.

Patient	Cause of PH	Child-Pugh Class	Acute bleed	Preoperative drug	Endoscopic findings	Endoscopic treatment	Volume of cyanoacrylate
(1) 57 y/F	PBC	A	No	None	F0/IGV 1	NBCA	3.5 ml
(2) 74 y/M	Alcohol	A	No	None	F2/GOV2	NBCA + EIS	3 ml
(3) 50 y/M	HCV	A	No	None	F3/GOV2	NBCA + EBL	3.5 ml
(4) 51 y/M	HBV	B	Yes	Aminomethylbenzoic acid 0.4 g; Etamsylate 2 g; Carbazochrome 80 mg; Hemocoagulase 1 IU; Somatostatin 6 mg	F3/GOV2	NBCA + EBL	2.5 ml
(5) 52 y/F	PBC	B	Yes	Carbazochrome 80 mg; Hemocoagulase 1 IU; Somatostatin 6 mg	F3/GOV2	NBCA + EBL	1 ml